Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pacemaker, Artificial | 13 | 2021 | 816 | 1.610 |
Why?
|
Tachycardia, Supraventricular | 13 | 2023 | 263 | 1.520 |
Why?
|
Tachycardia, Ventricular | 15 | 2022 | 1273 | 1.380 |
Why?
|
Heart Defects, Congenital | 28 | 2023 | 4584 | 1.340 |
Why?
|
Cardiac Pacing, Artificial | 12 | 2016 | 845 | 1.330 |
Why?
|
Catheter Ablation | 22 | 2023 | 2758 | 1.250 |
Why?
|
Arrhythmias, Cardiac | 13 | 2022 | 2268 | 1.190 |
Why?
|
Atrioventricular Block | 5 | 2022 | 120 | 1.180 |
Why?
|
Defibrillators, Implantable | 11 | 2022 | 1440 | 1.120 |
Why?
|
Heart Block | 10 | 2022 | 410 | 1.060 |
Why?
|
Accessory Atrioventricular Bundle | 6 | 2023 | 57 | 0.990 |
Why?
|
Electrocardiography | 34 | 2024 | 6442 | 0.970 |
Why?
|
Long QT Syndrome | 7 | 2017 | 453 | 0.940 |
Why?
|
Syncope | 7 | 2019 | 429 | 0.930 |
Why?
|
Electric Countershock | 8 | 2023 | 534 | 0.890 |
Why?
|
Death, Sudden, Cardiac | 9 | 2014 | 1541 | 0.870 |
Why?
|
Fontan Procedure | 7 | 2018 | 778 | 0.730 |
Why?
|
Exercise Test | 6 | 2022 | 2074 | 0.720 |
Why?
|
Heart Neoplasms | 2 | 2019 | 374 | 0.600 |
Why?
|
Wolff-Parkinson-White Syndrome | 4 | 2023 | 117 | 0.570 |
Why?
|
Ventricular Fibrillation | 5 | 2022 | 538 | 0.560 |
Why?
|
Heart Arrest | 3 | 2022 | 1470 | 0.530 |
Why?
|
Radio Waves | 1 | 2016 | 251 | 0.520 |
Why?
|
Child | 85 | 2024 | 77709 | 0.510 |
Why?
|
Bandages | 1 | 2016 | 266 | 0.500 |
Why?
|
Electrophysiologic Techniques, Cardiac | 7 | 2020 | 493 | 0.490 |
Why?
|
Equipment Failure | 7 | 2014 | 578 | 0.490 |
Why?
|
Heart Diseases | 7 | 2013 | 2788 | 0.470 |
Why?
|
Adolescent | 80 | 2023 | 85781 | 0.460 |
Why?
|
Central Nervous System Stimulants | 4 | 2015 | 1148 | 0.430 |
Why?
|
Foreign Bodies | 1 | 2016 | 399 | 0.420 |
Why?
|
Tachycardia | 3 | 2023 | 619 | 0.420 |
Why?
|
Child, Preschool | 51 | 2024 | 41006 | 0.410 |
Why?
|
Heart Conduction System | 7 | 2021 | 1047 | 0.410 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2022 | 1265 | 0.390 |
Why?
|
Syndactyly | 2 | 2014 | 72 | 0.380 |
Why?
|
Heart Septum | 4 | 2019 | 313 | 0.380 |
Why?
|
Anti-Arrhythmia Agents | 6 | 2023 | 789 | 0.370 |
Why?
|
Lyme Disease | 3 | 2021 | 621 | 0.370 |
Why?
|
Retrospective Studies | 54 | 2023 | 77449 | 0.360 |
Why?
|
Cardiac Resynchronization Therapy | 4 | 2018 | 531 | 0.350 |
Why?
|
Sotalol | 2 | 2020 | 49 | 0.350 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2020 | 585 | 0.340 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 4 | 2022 | 137 | 0.340 |
Why?
|
Heart Valve Prosthesis | 1 | 2017 | 1488 | 0.320 |
Why?
|
Infant | 34 | 2022 | 35136 | 0.320 |
Why?
|
Myocardium | 2 | 2019 | 4776 | 0.310 |
Why?
|
Atrial Flutter | 3 | 2023 | 263 | 0.300 |
Why?
|
Bundle-Branch Block | 3 | 2018 | 270 | 0.300 |
Why?
|
Myocarditis | 4 | 2021 | 771 | 0.300 |
Why?
|
Ebstein Anomaly | 2 | 2021 | 97 | 0.290 |
Why?
|
Aortic Valve | 1 | 2017 | 1922 | 0.290 |
Why?
|
Echocardiography | 13 | 2022 | 5102 | 0.290 |
Why?
|
Primary Prevention | 1 | 2014 | 1167 | 0.290 |
Why?
|
Rest | 1 | 2011 | 901 | 0.280 |
Why?
|
Transposition of Great Vessels | 3 | 2015 | 588 | 0.280 |
Why?
|
Ventricular Dysfunction, Left | 6 | 2024 | 2073 | 0.280 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 5 | 2015 | 3658 | 0.270 |
Why?
|
Chest Pain | 1 | 2013 | 1114 | 0.270 |
Why?
|
Dizziness | 1 | 2008 | 251 | 0.270 |
Why?
|
Cardiac Surgical Procedures | 5 | 2016 | 3537 | 0.270 |
Why?
|
Humans | 119 | 2024 | 744343 | 0.260 |
Why?
|
Young Adult | 37 | 2023 | 56430 | 0.260 |
Why?
|
Craniopharyngioma | 1 | 2008 | 281 | 0.260 |
Why?
|
Exercise | 3 | 2022 | 5615 | 0.250 |
Why?
|
Fluoroscopy | 3 | 2022 | 924 | 0.250 |
Why?
|
Heart Ventricles | 6 | 2018 | 3821 | 0.250 |
Why?
|
Exercise Therapy | 2 | 2022 | 906 | 0.240 |
Why?
|
Borrelia burgdorferi | 1 | 2006 | 180 | 0.240 |
Why?
|
Risk Assessment | 16 | 2022 | 23338 | 0.240 |
Why?
|
Electrodes, Implanted | 5 | 2010 | 824 | 0.240 |
Why?
|
Female | 85 | 2022 | 380194 | 0.240 |
Why?
|
Malnutrition | 1 | 2010 | 625 | 0.230 |
Why?
|
Pre-Excitation Syndromes | 2 | 2021 | 27 | 0.230 |
Why?
|
Autonomic Nervous System | 1 | 2008 | 671 | 0.230 |
Why?
|
Male | 84 | 2022 | 350118 | 0.230 |
Why?
|
Tachycardia, Ectopic Atrial | 3 | 2011 | 66 | 0.230 |
Why?
|
Ventricular Septum | 1 | 2023 | 73 | 0.220 |
Why?
|
Fetal Diseases | 3 | 2020 | 903 | 0.220 |
Why?
|
Heart Rate | 10 | 2020 | 4091 | 0.210 |
Why?
|
Boston | 15 | 2020 | 9313 | 0.210 |
Why?
|
Aortic Diseases | 1 | 2008 | 742 | 0.210 |
Why?
|
Aorta, Thoracic | 1 | 2008 | 1082 | 0.210 |
Why?
|
Ventricular Function, Left | 5 | 2018 | 3670 | 0.210 |
Why?
|
Abdominal Pain | 1 | 2008 | 1063 | 0.210 |
Why?
|
Anorexia Nervosa | 1 | 2010 | 1286 | 0.200 |
Why?
|
Oxygen Consumption | 4 | 2023 | 1869 | 0.200 |
Why?
|
Oxyhemoglobins | 1 | 2022 | 216 | 0.190 |
Why?
|
Steroids | 1 | 2005 | 930 | 0.180 |
Why?
|
Tetralogy of Fallot | 5 | 2013 | 623 | 0.180 |
Why?
|
Treatment Outcome | 33 | 2022 | 63114 | 0.180 |
Why?
|
Infant, Newborn | 18 | 2022 | 25625 | 0.180 |
Why?
|
Heart Rate, Fetal | 1 | 2020 | 75 | 0.180 |
Why?
|
Technology | 1 | 2022 | 305 | 0.180 |
Why?
|
Pituitary Neoplasms | 1 | 2008 | 1345 | 0.170 |
Why?
|
Adult | 44 | 2024 | 214055 | 0.170 |
Why?
|
Procainamide | 1 | 2018 | 61 | 0.170 |
Why?
|
Heart | 2 | 2010 | 4467 | 0.170 |
Why?
|
Physical Fitness | 1 | 2023 | 733 | 0.170 |
Why?
|
Recurrence | 9 | 2022 | 8340 | 0.160 |
Why?
|
Fetal Heart | 1 | 2020 | 276 | 0.160 |
Why?
|
Myocardial Revascularization | 1 | 2002 | 841 | 0.160 |
Why?
|
Risk Factors | 24 | 2020 | 72290 | 0.160 |
Why?
|
Atrial Fibrillation | 4 | 2023 | 5034 | 0.150 |
Why?
|
Amiodarone | 1 | 2018 | 212 | 0.150 |
Why?
|
Hospitalization | 3 | 2021 | 10262 | 0.150 |
Why?
|
Incidence | 10 | 2020 | 20947 | 0.140 |
Why?
|
Time Factors | 11 | 2020 | 40075 | 0.140 |
Why?
|
Cardiac Output | 1 | 2018 | 854 | 0.140 |
Why?
|
Saxitoxin | 1 | 2015 | 65 | 0.130 |
Why?
|
Regional Health Planning | 1 | 2016 | 97 | 0.130 |
Why?
|
Models, Statistical | 1 | 2010 | 5102 | 0.130 |
Why?
|
Sports | 2 | 2020 | 688 | 0.130 |
Why?
|
Heart Bypass, Right | 1 | 2015 | 74 | 0.130 |
Why?
|
Punctures | 2 | 2013 | 374 | 0.120 |
Why?
|
Follow-Up Studies | 19 | 2022 | 39050 | 0.120 |
Why?
|
Statistics, Nonparametric | 4 | 2012 | 2886 | 0.120 |
Why?
|
Social Class | 1 | 2023 | 1999 | 0.120 |
Why?
|
Heart Atria | 3 | 2016 | 1357 | 0.120 |
Why?
|
Tendons | 1 | 2018 | 548 | 0.120 |
Why?
|
Radiation Dosage | 2 | 2013 | 1928 | 0.110 |
Why?
|
Anesthesia, General | 2 | 2022 | 1171 | 0.110 |
Why?
|
Telemetry | 2 | 2020 | 205 | 0.110 |
Why?
|
Survival Rate | 8 | 2014 | 12788 | 0.110 |
Why?
|
Survival Analysis | 6 | 2011 | 10252 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 275 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2014 | 12354 | 0.110 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1585 | 0.110 |
Why?
|
Mass Screening | 4 | 2012 | 5255 | 0.110 |
Why?
|
Patient Selection | 2 | 2015 | 4215 | 0.110 |
Why?
|
Predictive Value of Tests | 9 | 2020 | 15076 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 15165 | 0.110 |
Why?
|
Rett Syndrome | 1 | 2014 | 165 | 0.100 |
Why?
|
Monitoring, Physiologic | 2 | 2018 | 1738 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 792 | 0.100 |
Why?
|
Bradycardia | 1 | 2014 | 307 | 0.100 |
Why?
|
Isolated Noncompaction of the Ventricular Myocardium | 1 | 2011 | 22 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 411 | 0.100 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2013 | 151 | 0.100 |
Why?
|
Critical Pathways | 1 | 2016 | 476 | 0.100 |
Why?
|
Matrix Metalloproteinase 3 | 1 | 2012 | 134 | 0.100 |
Why?
|
Eligibility Determination | 1 | 2015 | 403 | 0.100 |
Why?
|
Ventricular Function, Right | 1 | 2015 | 591 | 0.100 |
Why?
|
Uncertainty | 1 | 2016 | 734 | 0.100 |
Why?
|
Amphetamines | 1 | 2012 | 148 | 0.100 |
Why?
|
Costello Syndrome | 1 | 2011 | 19 | 0.100 |
Why?
|
Body Surface Potential Mapping | 2 | 2010 | 238 | 0.100 |
Why?
|
Hemodynamics | 3 | 2016 | 4199 | 0.100 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2013 | 488 | 0.090 |
Why?
|
Hypoplastic Left Heart Syndrome | 1 | 2016 | 574 | 0.090 |
Why?
|
Emergency Service, Hospital | 3 | 2021 | 7659 | 0.090 |
Why?
|
Postoperative Complications | 3 | 2013 | 15295 | 0.090 |
Why?
|
Prevalence | 8 | 2022 | 15226 | 0.090 |
Why?
|
Cardiovascular Abnormalities | 1 | 2011 | 144 | 0.090 |
Why?
|
Age Factors | 8 | 2018 | 18370 | 0.090 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2015 | 581 | 0.090 |
Why?
|
Equipment Failure Analysis | 2 | 2009 | 868 | 0.090 |
Why?
|
Heart Function Tests | 1 | 2010 | 330 | 0.090 |
Why?
|
Pulmonary Valve | 1 | 2013 | 437 | 0.090 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.090 |
Why?
|
Cardiology | 2 | 2016 | 1668 | 0.090 |
Why?
|
Sick Sinus Syndrome | 1 | 2009 | 44 | 0.090 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2015 | 851 | 0.080 |
Why?
|
Cohort Studies | 11 | 2022 | 40561 | 0.080 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 4776 | 0.080 |
Why?
|
Heart Failure | 5 | 2015 | 10900 | 0.080 |
Why?
|
Physical Exertion | 1 | 2011 | 695 | 0.080 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2418 | 0.080 |
Why?
|
Friedreich Ataxia | 1 | 2008 | 76 | 0.080 |
Why?
|
Methylphenidate | 1 | 2012 | 473 | 0.080 |
Why?
|
Prosthesis Design | 1 | 2014 | 2110 | 0.080 |
Why?
|
Troponin T | 1 | 2012 | 754 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2021 | 3679 | 0.070 |
Why?
|
Dilatation, Pathologic | 1 | 2008 | 520 | 0.070 |
Why?
|
Endosonography | 1 | 2010 | 610 | 0.070 |
Why?
|
Ventricular Function | 1 | 2008 | 416 | 0.070 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1676 | 0.070 |
Why?
|
Prostheses and Implants | 2 | 2019 | 1387 | 0.070 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2018 | 1534 | 0.070 |
Why?
|
Tilt-Table Test | 1 | 2006 | 78 | 0.070 |
Why?
|
Electromagnetic Fields | 1 | 2008 | 298 | 0.070 |
Why?
|
Systole | 2 | 2005 | 958 | 0.070 |
Why?
|
Radiography, Interventional | 1 | 2013 | 1095 | 0.070 |
Why?
|
Computers, Handheld | 1 | 2008 | 208 | 0.070 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2014 | 2015 | 0.070 |
Why?
|
Abnormalities, Multiple | 1 | 2013 | 1416 | 0.070 |
Why?
|
Sensitivity and Specificity | 6 | 2013 | 14722 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2011 | 1285 | 0.070 |
Why?
|
Comorbidity | 5 | 2013 | 10388 | 0.070 |
Why?
|
Decision Support Techniques | 1 | 2016 | 1956 | 0.070 |
Why?
|
Pain | 2 | 2022 | 4986 | 0.070 |
Why?
|
ras Proteins | 1 | 2011 | 1060 | 0.070 |
Why?
|
Autistic Disorder | 1 | 2014 | 1185 | 0.060 |
Why?
|
Axillary Vein | 1 | 2004 | 16 | 0.060 |
Why?
|
Device Removal | 1 | 2010 | 656 | 0.060 |
Why?
|
Surgery, Computer-Assisted | 1 | 2013 | 1018 | 0.060 |
Why?
|
Diagnosis, Differential | 3 | 2021 | 12959 | 0.060 |
Why?
|
Subclavian Vein | 1 | 2004 | 54 | 0.060 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7279 | 0.060 |
Why?
|
Complex Regional Pain Syndromes | 1 | 2006 | 124 | 0.060 |
Why?
|
Coronary Vessels | 2 | 2006 | 3107 | 0.060 |
Why?
|
Syncope, Vasovagal | 1 | 2004 | 38 | 0.060 |
Why?
|
Prosthesis Implantation | 1 | 2009 | 642 | 0.060 |
Why?
|
Calcium Channels, L-Type | 1 | 2005 | 240 | 0.060 |
Why?
|
Posture | 1 | 2008 | 958 | 0.060 |
Why?
|
Propafenone | 1 | 2023 | 27 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2010 | 1240 | 0.060 |
Why?
|
Chi-Square Distribution | 2 | 2011 | 3508 | 0.060 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2007 | 349 | 0.060 |
Why?
|
Disease Management | 1 | 2014 | 2459 | 0.060 |
Why?
|
Prospective Studies | 10 | 2021 | 53288 | 0.060 |
Why?
|
Flecainide | 1 | 2023 | 42 | 0.060 |
Why?
|
MAP Kinase Signaling System | 1 | 2011 | 1526 | 0.060 |
Why?
|
Stroke Volume | 3 | 2015 | 5007 | 0.060 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2006 | 257 | 0.060 |
Why?
|
Bundle of His | 1 | 2023 | 87 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2013 | 1536 | 0.060 |
Why?
|
Pediatrics | 2 | 2016 | 3475 | 0.050 |
Why?
|
Logistic Models | 3 | 2009 | 13408 | 0.050 |
Why?
|
Information Storage and Retrieval | 1 | 2008 | 824 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2012 | 1154 | 0.050 |
Why?
|
Cardiomyopathies | 2 | 2011 | 1912 | 0.050 |
Why?
|
Inpatients | 1 | 2013 | 2518 | 0.050 |
Why?
|
Pandemics | 1 | 2021 | 8388 | 0.050 |
Why?
|
Algorithms | 2 | 2016 | 13881 | 0.050 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3057 | 0.050 |
Why?
|
Veins | 1 | 2005 | 770 | 0.050 |
Why?
|
Heart Transplantation | 1 | 2014 | 3110 | 0.050 |
Why?
|
Cryosurgery | 1 | 2006 | 453 | 0.050 |
Why?
|
Prostaglandins | 1 | 2022 | 405 | 0.050 |
Why?
|
Palliative Care | 1 | 2016 | 3493 | 0.050 |
Why?
|
Blood Pressure | 2 | 2015 | 8554 | 0.050 |
Why?
|
Cost-Benefit Analysis | 2 | 2012 | 5391 | 0.050 |
Why?
|
United States | 7 | 2020 | 69872 | 0.050 |
Why?
|
Physicians, Family | 1 | 2003 | 345 | 0.050 |
Why?
|
Recovery of Function | 1 | 2011 | 2925 | 0.050 |
Why?
|
Action Potentials | 2 | 2020 | 1806 | 0.050 |
Why?
|
Genetic Testing | 2 | 2020 | 3444 | 0.050 |
Why?
|
Prognosis | 7 | 2020 | 29063 | 0.050 |
Why?
|
Catheters | 1 | 2023 | 425 | 0.040 |
Why?
|
Cerebral Cortex | 1 | 2016 | 5708 | 0.040 |
Why?
|
Syndrome | 1 | 2005 | 3251 | 0.040 |
Why?
|
Middle Aged | 19 | 2014 | 213383 | 0.040 |
Why?
|
North America | 2 | 2018 | 1249 | 0.040 |
Why?
|
Electric Stimulation | 1 | 2004 | 1767 | 0.040 |
Why?
|
Ambulatory Care | 2 | 2016 | 2708 | 0.040 |
Why?
|
California | 1 | 2002 | 1402 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2024 | 859 | 0.040 |
Why?
|
Fetal Death | 1 | 2020 | 448 | 0.040 |
Why?
|
Maternal-Fetal Exchange | 1 | 2020 | 456 | 0.040 |
Why?
|
Treatment Failure | 1 | 2004 | 2618 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2006 | 1161 | 0.040 |
Why?
|
Age Distribution | 1 | 2004 | 2902 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.040 |
Why?
|
Homeostasis | 1 | 2008 | 3340 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2015 | 13989 | 0.040 |
Why?
|
Reproducibility of Results | 5 | 2018 | 19905 | 0.040 |
Why?
|
Seasons | 1 | 2002 | 1493 | 0.040 |
Why?
|
Mutation, Missense | 1 | 2005 | 2564 | 0.030 |
Why?
|
Observer Variation | 2 | 2018 | 2593 | 0.030 |
Why?
|
District of Columbia | 1 | 2015 | 157 | 0.030 |
Why?
|
Preoperative Care | 2 | 2014 | 2250 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 109 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2018 | 10943 | 0.030 |
Why?
|
Fetal Mortality | 1 | 2014 | 19 | 0.030 |
Why?
|
Hospitals, Pediatric | 2 | 2015 | 1775 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2018 | 2274 | 0.030 |
Why?
|
Postoperative Care | 1 | 2020 | 1486 | 0.030 |
Why?
|
Linear Models | 2 | 2015 | 5952 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.030 |
Why?
|
New England | 1 | 2016 | 1022 | 0.030 |
Why?
|
Differential Threshold | 1 | 2012 | 80 | 0.030 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 1 | 2012 | 99 | 0.030 |
Why?
|
Matrix Metalloproteinase 1 | 1 | 2012 | 141 | 0.030 |
Why?
|
Medical History Taking | 1 | 2016 | 783 | 0.030 |
Why?
|
Models, Biological | 1 | 2008 | 9583 | 0.030 |
Why?
|
Ultrasonography, Prenatal | 1 | 2020 | 1695 | 0.030 |
Why?
|
Rhabdomyoma | 1 | 2011 | 57 | 0.020 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2013 | 272 | 0.020 |
Why?
|
Gestational Age | 1 | 2020 | 3493 | 0.020 |
Why?
|
Cross-Over Studies | 2 | 2008 | 2029 | 0.020 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2016 | 721 | 0.020 |
Why?
|
Postmortem Changes | 1 | 2011 | 126 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Myxoma | 1 | 2011 | 130 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2002 | 2624 | 0.020 |
Why?
|
Propanolamines | 1 | 2011 | 167 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2214 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2015 | 5317 | 0.020 |
Why?
|
Databases, Factual | 2 | 2015 | 7729 | 0.020 |
Why?
|
Guideline Adherence | 2 | 2016 | 2266 | 0.020 |
Why?
|
Disease-Free Survival | 2 | 2015 | 6895 | 0.020 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 25043 | 0.020 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2012 | 472 | 0.020 |
Why?
|
Insurance, Health | 1 | 2002 | 2494 | 0.020 |
Why?
|
Fibroma | 1 | 2011 | 212 | 0.020 |
Why?
|
Physical Examination | 1 | 2016 | 1237 | 0.020 |
Why?
|
Edema | 1 | 2014 | 789 | 0.020 |
Why?
|
Electrophysiology | 1 | 2012 | 1308 | 0.020 |
Why?
|
Carbazoles | 1 | 2011 | 226 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2013 | 8642 | 0.020 |
Why?
|
Infant Mortality | 1 | 2014 | 754 | 0.020 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2012 | 638 | 0.020 |
Why?
|
Equipment Design | 2 | 2008 | 3582 | 0.020 |
Why?
|
Internationality | 1 | 2014 | 1003 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 985 | 0.020 |
Why?
|
Vital Capacity | 1 | 2011 | 925 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2012 | 3610 | 0.020 |
Why?
|
Health Promotion | 1 | 2020 | 2205 | 0.020 |
Why?
|
Health Planning Guidelines | 1 | 2008 | 163 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 864 | 0.020 |
Why?
|
Cardiotonic Agents | 1 | 2011 | 535 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1590 | 0.020 |
Why?
|
Medication Therapy Management | 1 | 2008 | 127 | 0.020 |
Why?
|
Europe | 1 | 2014 | 3339 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2362 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2018 | 8301 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2016 | 15540 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2488 | 0.020 |
Why?
|
Length of Stay | 1 | 2020 | 6309 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12245 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2015 | 12026 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 21746 | 0.020 |
Why?
|
Prenatal Diagnosis | 1 | 2014 | 1236 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2018 | 1797 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.020 |
Why?
|
Registries | 2 | 2015 | 8089 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2011 | 1743 | 0.020 |
Why?
|
Analgesics, Opioid | 1 | 2022 | 3674 | 0.020 |
Why?
|
Quality-Adjusted Life Years | 1 | 2012 | 1683 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3420 | 0.020 |
Why?
|
Pregnancy | 2 | 2020 | 29144 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2006 | 6365 | 0.020 |
Why?
|
Fibrosis | 1 | 2012 | 2029 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6489 | 0.020 |
Why?
|
Phlebography | 1 | 2006 | 333 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 3870 | 0.020 |
Why?
|
Infant, Premature | 1 | 2014 | 2044 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6622 | 0.010 |
Why?
|
Therapeutic Irrigation | 1 | 2005 | 301 | 0.010 |
Why?
|
American Heart Association | 1 | 2008 | 1056 | 0.010 |
Why?
|
Pregnancy Outcome | 1 | 2014 | 2795 | 0.010 |
Why?
|
Atrioventricular Node | 1 | 2004 | 182 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 1692 | 0.010 |
Why?
|
Body Size | 1 | 2006 | 461 | 0.010 |
Why?
|
Acute Disease | 1 | 2013 | 7149 | 0.010 |
Why?
|
Neural Conduction | 1 | 2004 | 440 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16365 | 0.010 |
Why?
|
Societies, Medical | 1 | 2014 | 3743 | 0.010 |
Why?
|
Cold Temperature | 1 | 2005 | 772 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
Blotting, Western | 1 | 2009 | 5179 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2002 | 11727 | 0.010 |
Why?
|
Aged | 5 | 2008 | 163280 | 0.010 |
Why?
|
United States Food and Drug Administration | 1 | 2008 | 1584 | 0.010 |
Why?
|
Coronary Artery Disease | 2 | 2012 | 6487 | 0.010 |
Why?
|
Ultrasonography | 1 | 2013 | 5985 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6538 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3507 | 0.010 |
Why?
|
Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.010 |
Why?
|
Radiography | 1 | 2009 | 7023 | 0.010 |
Why?
|
Child Welfare | 1 | 2002 | 523 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2008 | 5078 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 2003 | 850 | 0.010 |
Why?
|
Brain | 1 | 2022 | 26385 | 0.010 |
Why?
|
Genotype | 1 | 2008 | 12951 | 0.010 |
Why?
|
Lung | 1 | 2011 | 9856 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168757 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2003 | 57776 | 0.000 |
Why?
|